SPARKS, Nev., Feb. 25, 2004 (PRIMEZONE) -- ABSS, Corp. (OTCBB:ABSP), a publicly traded holding company, has announced that its President, Alan Lew was recently named Director of Operations for the International Conference on Mechanisms of Action of Nutraceuticals. Said Lew, "This is a great honor to work along side many internationally re-known researchers, clinicians and physicians." He further commented, "We hope to build a successful 2004 Conference which is scheduled for this November."
The Organizing Committee of ICMAN stated, "We are extremely pleased to add Mr. Lew to our team, as he brings valuable skills and experience to our organization."
The preceding statements that are not historical facts are based on the Company's current expectations and are subject to the caveat for safe harbor statements appearing below.
About International Conference on Mechanisms of Action of Nutraceuticals (ICMAN)
In its third year of operation, the mission of ICMAN 3 is to provide a forum for researchers, clinicians, regulatory and industry leaders to present and discuss current developments relevant to the application of nutraceuticals to chronic illnesses and other conditions. The 2004 Conference is tentatively set to be in November, in North Carolina. For more information, see www.ICMAN3.org
About ABSS, Corp.
ABSS, Corp. is a publicly traded holding company looking to merge or acquire operating business entities.
Safe Harbor Statement Caveat
"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements that are subject to risks and uncertainties, including, but not limited to, the impact of competitive products and pricing, product demand and market acceptance, new product development, reliance on key strategic alliances, availability of raw material, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the company's filings with the Securities and Exchange Commission.